Description de l'entreprise
The Siegfried Group is a global life sciences company with facilities located in Switzerland, the USA, Malta, China, Germany and France. Siegfried is active in primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with R& D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings.
Conseil d'administration & Conseil de surveillance
| PDG |
| Marcel Imwinkelried |
| Conseil d'administration |
| Reto Suter, Henrik Krüpper, Dr. Jürgen Roos, Marianne Späne, Irene Wosgien |
| Conseil de surveillance |
| Dr. Andreas Casutt, Dr. Martin Schmid, Alexandra Brand, Wolfram Carius, Elodie Carr-Cingari, Beat Walti, Isabelle Welton |
Données de l'entreprise
| Nom: |
Siegfried Holding AG |
| Adresse: |
Untere Brühlstraße 4,CH-4800 Zofingen |
| Téléphone: |
+41-62-746-1111 |
| Fax: |
+41-62-746-1202 |
| Courriel: |
info@siegfried.ch
|
| Internet: |
www.siegfried.ch |
| Industrie: |
Commodities |
| Secteur: |
Chemicals |
| Sous-secteur: |
- |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
75.10% |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Reto Suter |
| Téléphone IR: |
+41-62-746-15-35 |
| IR-Fax: |
- |
| E-mail IR: |
reto.suter@siegfried.ch
|
